• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部免疫相关不良事件的影像学特征。

Imaging Features of Pulmonary Immune-related Adverse Events.

机构信息

Department of Radiology, AUSL Toscana Centro, San Giuseppe Hospital, Empoli, Italy; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Respiratory Medicine Department, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

出版信息

J Thorac Oncol. 2021 Sep;16(9):1449-1460. doi: 10.1016/j.jtho.2021.05.017. Epub 2021 Jun 1.

DOI:10.1016/j.jtho.2021.05.017
PMID:34087477
Abstract

Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection and correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both high-resolution computed tomography and positron emission tomography/computed tomography and stress their underlying diagnostic challenge by presenting the mimickers.

摘要

肺免疫相关不良事件是免疫治疗罕见但潜在严重的副作用。由于症状和影像学特征不具有特异性,可能与其他肺部疾病相似,从而可能延迟对患者的适当管理,因此诊断通常具有挑战性。在这种情况下,准确的影像学评估对于及时发现和正确管理这些药物引起的肺部疾病至关重要。本文的目的是回顾不同类型的肺免疫相关不良事件,描述它们在高分辨率计算机断层扫描和正电子发射断层扫描/计算机断层扫描上的影像学特征,并通过呈现这些疾病的模拟疾病来强调其潜在的诊断挑战。

相似文献

1
Imaging Features of Pulmonary Immune-related Adverse Events.肺部免疫相关不良事件的影像学特征。
J Thorac Oncol. 2021 Sep;16(9):1449-1460. doi: 10.1016/j.jtho.2021.05.017. Epub 2021 Jun 1.
2
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.肺癌中程序性细胞死亡蛋白-1轴抑制剂相关免疫相关不良事件的监测与管理
Oncologist. 2017 Jan;22(1):70-80. doi: 10.1634/theoncologist.2016-0164. Epub 2016 Aug 17.
3
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update.免疫检查点阻断治疗转移性黑色素瘤中 CTLA-4 和 PD-1 抗体的副作用管理 - 最新进展。
J Dtsch Dermatol Ges. 2020 Jun;18(6):582-609. doi: 10.1111/ddg.14128. Epub 2020 Jun 3.
4
Immunotherapy-related adverse effects on F-FDG PET/CT imaging.免疫治疗相关的 F-FDG PET/CT 成像不良反应。
Br J Radiol. 2020 Jul;93(1111):20190832. doi: 10.1259/bjr.20190832. Epub 2020 Feb 27.
5
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.免疫检查点抑制剂和 COVID-19 引起的肺炎:癌症治疗中的当前关注点。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000952.
6
Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis.免疫相关不良事件与非小细胞肺癌的程序性细胞死亡蛋白-1 和程序性死亡配体 1 抑制剂相关:PRISMA 系统评价和荟萃分析。
BMC Cancer. 2019 Jun 10;19(1):558. doi: 10.1186/s12885-019-5701-6.
7
Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗患者免疫相关不良事件发生、分级和时间评估的差异。
JAMA Netw Open. 2019 Sep 4;2(9):e1911519. doi: 10.1001/jamanetworkopen.2019.11519.
8
What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events.关于癌症免疫疗法我们了解多少?长期生存和免疫相关不良事件。
Allergol Immunopathol (Madr). 2019 May-Jun;47(3):303-308. doi: 10.1016/j.aller.2018.04.005. Epub 2018 Jul 6.
9
Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab.患者接受派姆单抗治疗转移性黑色素瘤后出现多种免疫检查点抑制剂相关的自身免疫副作用。
J Oncol Pharm Pract. 2021 Jan;27(1):207-211. doi: 10.1177/1078155220921543. Epub 2020 May 9.
10
Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells.免疫检查点抑制剂相关不良事件的免疫发病机制:肠道微生物组和 Th17 细胞的作用。
Front Immunol. 2019 Sep 26;10:2254. doi: 10.3389/fimmu.2019.02254. eCollection 2019.

引用本文的文献

1
Balancing Innovation and Safety: Prediction, Prevention, and Management of Pneumonitis in Lung Cancer Patients Receiving Novel Anti-Cancer Agents.平衡创新与安全:肺癌患者接受新型抗癌药物治疗时肺炎的预测、预防与管理
Cancers (Basel). 2025 Jul 30;17(15):2522. doi: 10.3390/cancers17152522.
2
Imaging features and prognostic significance of immune checkpoint inhibitor-related pneumonitis in NSCLC.非小细胞肺癌中免疫检查点抑制剂相关肺炎的影像学特征及预后意义
BMC Cancer. 2025 Jul 19;25(1):1192. doi: 10.1186/s12885-025-14628-5.
3
Expert consensus on cancer treatment-related lung injury.
癌症治疗相关肺损伤专家共识
J Thorac Dis. 2025 Apr 30;17(4):1844-1875. doi: 10.21037/jtd-2025-292. Epub 2025 Apr 28.
4
Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review.免疫检查点抑制剂和CAR-T细胞疗法诱导的免疫相关不良事件:基于影像学的综合综述
Cancers (Basel). 2024 Jul 19;16(14):2585. doi: 10.3390/cancers16142585.
5
Is F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons.F-FDG-PET/CT是检测免疫检查点抑制剂治疗后免疫相关不良事件的最佳成像方式吗?利弊分析。
Cancers (Basel). 2024 May 24;16(11):1990. doi: 10.3390/cancers16111990.
6
Uncommon Causes of Interlobular Septal Thickening on CT Images and Their Distinguishing Features.CT 图像上小叶间隔增厚的不常见病因及其鉴别特征。
Tomography. 2024 Apr 17;10(4):574-608. doi: 10.3390/tomography10040045.
7
Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer.病例报告:在免疫检查点抑制剂联合放疗治疗肺鳞癌中,肺炎的临床症状先于影像学证据出现。
Front Immunol. 2022 Sep 15;13:998516. doi: 10.3389/fimmu.2022.998516. eCollection 2022.
8
Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review.非小细胞肺癌中免疫检查点抑制剂相关肺炎:综述
Front Oncol. 2022 Aug 16;12:911906. doi: 10.3389/fonc.2022.911906. eCollection 2022.